I am an Assistant Professor of Biomedical Engineering and Computer Science at Duke University. Research in my Programmable Biology Group exists at the interface of generative AI and protein engineering to design platforms for applications in genome, proteome, and cell engineering. A PhD graduate of the MIT Media Lab, I developed robust genome editing technologies that represent some of the broadest, safest, and most effective CRISPR enzymes to date. More recently, my research has extended to the emergent field of “proteome” editing, where our team leverages language model-based design to engineer potent peptide fusions that target and degrade pathogenic proteins, including those implicated in viral diseases and cancer. Our established expertise in AI are further being applied to develop transcription factor-based stem cell differentiation protocols for reproductive cell types.
I am also very passionate about translating my academic research to the clinic as efficiently as possible. As such, I have co-founded two companies, UbiquiTx, Inc. and Gameto Inc., which are building upon my foundational research to develop novel protein-based cancer therapeutics and fertility solutions, respectively. Most importantly, I am a firm believer in the power of conducting impactful science in an inclusive and supportive environment. As such, I have been determined and active in creating academic and community environments that welcome students of diverse backgrounds to science and engineering.